Why this checklist exists
International dental clinics market to UK patients through a wide range of channels — paid search, social media, traveller-review sites, comparison platforms, and direct referrals from previous patients. The marketing surface is often polished and the headline figures look reasonable, but the structural questions a UK patient needs to answer before committing are not the questions the marketing surface is engineered to answer. The checklist below exists to make those structural questions visible, regardless of which provider the patient is currently considering.
The seven points are arranged in clinical sequence rather than commercial sequence. They begin at the clinician — who is the named individual who will read the case and place the implant — and end at the manufacturer's implant passport — the document the patient travels with for any future review years after the surgical visit. The intermediate points cover facility accreditation, remote case review, written estimate, imaging integration, and aftercare cadence. Each is a structural feature rather than a marketing line, and each can be verified in writing before any deposit is taken.
The checklist is provider-agnostic. It applies equally to a standalone overseas clinic, a marketplace aggregator, and a UK-registered care coordinator. The aim is not to point the reader at any one provider but to give the reader a structured way to read whichever provider the reader is currently weighing. Where a provider declines to answer one or more of the seven points in writing, that itself is useful structural information about the model the provider operates under.
Point 1 — Verify the practising clinician's name and credentials before any deposit
The single most important structural fact in any overseas dental pathway is who the named treating clinician is. The clinician's full name, professional title, sub-specialty, years of practice, and registration with the relevant national professional body should be documented in writing before any deposit is requested. Anonymised authority — "experienced surgeons", "a team of specialists", "leading implantologists" — is not a clinical signal. It is a marketing line, and it should be read as such.
The verification step is straightforward. The clinician's name can be checked against the public register of the relevant national dental council. In the UK that register is the General Dental Council (GDC). In Turkey, the Turkish Dental Association maintains a comparable register, and many partner clinicians additionally hold European Association for Osseointegration (EAO) membership, prosthodontic specialisation, or maxillofacial surgical credentials that can be verified independently against the relevant body. Where the clinician's credential carries an individual identifier, the patient should be able to read that identifier in writing.
Where a provider declines to name the treating clinician until after the patient arrives in-country, that is structurally different from naming the clinician at the evaluation stage. Both arrangements occur in the international dental market, but the structural difference matters. A patient who reads the verified clinician's credential before booking can verify it independently, can ask their UK dentist to comment on the discipline match, and can decline to proceed without travelling. A patient who learns the clinician's name on arrival has fewer of those options.
The ATDERA Care Network publishes the verified partner clinician for each treatment area on the relevant treatment page, with current written permission to be publicly named held in ATDERA's editorial registry. The clinician's credential is documented at the evaluation stage, surfaced in writing on the case-specific estimate, and the same clinician is on file in the post-operative review schedule rather than a rotating roster. This is the structural shape the first checklist point asks the patient to look for, regardless of which provider the patient is weighing.
Point 2 — Confirm the facility's accreditation (JCI / ISO / national equivalent)
Facility accreditation is a separate clinical signal from the clinician's individual credential. A clinician can be highly credentialled and a facility can be poorly run, or a facility can carry recognised accreditation with a clinician roster that turns over rapidly. Both signals matter, and the patient should read both independently. The most widely cited international facility accreditation is Joint Commission International (JCI), a US-headquartered organisation that audits hospital and clinic facilities against an internationally recognised standard. ISO 9001 quality-management certification and national accreditation bodies are additional signals.
JCI accreditation is verifiable through the JCI public register at jointcommissioninternational.org, which lists every accredited organisation by country and accreditation date. A facility that claims JCI accreditation but does not appear on the public register is not currently accredited. ISO certification is similarly verifiable through the certifying body. National accreditation in Turkey is available through the Türkiye Sağlık Hizmetleri Kalite ve Akreditasyon Enstitüsü (TÜSKA) and equivalent bodies. The patient should be able to read the accreditation reference and verify it against the relevant register before committing to travel.
Accreditation is a facility-level signal — sterilisation protocols, surgical infrastructure, clinical governance, patient-record handling, infection control. It is not a per-clinician verification, and it does not substitute for reading the verified clinician's credential. The two signals are designed to be read in parallel: the facility accreditation tells the patient what the surgical environment is held to, and the clinician credential tells the patient who is operating in that environment for the patient's specific case. Both should be verifiable in writing before the patient travels.
Point 3 — Insist on a remote case review with the verified clinician, not a sales coordinator
A remote case review is the clinical conversation that happens before any travel plan is made. It reads the patient's CBCT scan, panoramic radiograph, clinical history, and photographic record, and produces a written summary covering the recommended pathway, the rationale, any adjunctive procedure required, and the proposed treatment timeline. The conversation is clinical rather than commercial, and it is conducted by the verified clinician who would treat the case rather than by an international patient liaison whose role is to convert enquiries.
The structural difference between a clinical case review and a sales conversation is visible in the written output. A clinical case review names the units to be treated, the implant trajectory, the residual bone volume, the chosen ceramic system, and any adjunctive procedure such as bone grafting or sinus floor elevation. A sales conversation references a headline figure, an indicative timeline, and a generic procedure name. The first is auditable by the patient's UK dentist; the second is not.
Where the provider's first response to a clinical question is a price quote, that is a structural signal. Where the response is a written summary of the verified clinician's reading of the imaging — including any contraindication, prerequisite step, or alternative recommendation — that is a different kind of conversation. The patient should be able to read the clinician's written summary before reading any line-item value, and the patient's UK or home-country dentist should be able to read the summary independently if a second opinion is sought.
The remote case review is the gating step in the ATDERA pathway. Where the imaging is sufficient for planning, the verified partner clinician reviews the case and confirms candidacy in writing, typically within one to three working days. Where the imaging is older than twelve months or insufficient for surgical planning, a fresh CBCT is scheduled in-country before the surgical visit, but the candidacy decision and the written estimate are issued before any travel plan is made. This is the structural shape the third checklist point asks the patient to look for.
Point 4 — Read the written, customised estimate before any travel plan
A headline figure — "full-arch implants from £X,XXX" or "single implant £X,XXX, all-in" — is a marketing instrument, not a clinical estimate. It does not separate the clinician fee from the implant brand from the prosthesis material from the surgical complexity from any adjunctive procedure. It does not allow the patient or the patient's UK dentist to read each clinical component independently. It is reverse-engineered from a competitive position rather than forward-built from the case itself, and it should not be the document the patient signs against.
A customised written estimate is structurally different. Each clinical component is listed as a separate line item with a clinical name and a numeric value: the clinician fee for the placement and prosthetic-fitting visits, the implant brand and system, the prosthesis material and laboratory work, the surgical complexity (single-stage versus immediate-loading versus staged with adjunctive procedures), and any adjunctive procedure such as bone grafting, sinus floor elevation, or extraction of a non-restorable adjacent tooth. Travel logistics are referenced separately and are never bundled into the clinical estimate.
The line-item structure matters because it makes the financial picture independently auditable. A patient who reads the estimate alongside their UK or home-country dentist can identify which components are unusually high or low, which implant brand is being quoted, what the prosthesis material is, and what adjunctive procedure has been added. The patient is not reading a competitive headline; the patient is reading a clinical document. Where the estimate cannot be read line by line, the financial picture cannot be audited, and the patient is signing against a structure they cannot verify.
The fourth checklist point asks the patient to insist on a written, customised estimate before any travel plan is made — and to set the estimate alongside any UK private quote on the same case, on the same line-item basis. A side-by-side reading on equivalent terms is the only way to read the structural cost difference between the two markets. A side-by-side reading on headline figures is a marketing comparison, not a clinical one.
Point 5 — Check imaging integration — what scans are accepted, what is repeated, what is itemised
Imaging is the single most important diagnostic in implant planning, and the way an overseas provider handles existing imaging is a structural signal. The patient may already hold a recent CBCT, panoramic radiograph, and intra-oral scan from a UK private practice. A responsibly run pathway reads the existing imaging where it meets the surgical-planning protocol — file format (typically DICOM for CBCT), date of acquisition (typically within the last twelve months), and field-of-view coverage of the planned surgical area. Where the imaging meets those criteria, the case is reviewed remotely against it without a fresh scan being added.
Where the existing imaging is older than twelve months, in a non-readable file format, or taken to a protocol the partner clinician cannot use for surgical planning, a fresh CBCT is scheduled in-country before the surgical visit. The reason for the repeat is documented in writing in the case review summary, and the cost of the in-country scan is itemised as a separate line item rather than absorbed into a headline figure. The patient reads the rationale before agreeing to the repeat scan, and the patient's home dentist can comment on the rationale if helpful.
Where a provider repeats every patient's imaging in-country regardless of the existing scan, that is a structural signal worth reading carefully. The repeat may be clinically warranted in every case, but it may also reflect a default revenue line rather than a clinical decision. A pathway that documents the imaging-integration decision in writing — what scans are accepted, what is repeated, what is itemised — is structurally different from one that defaults the patient through a fresh imaging stage without reference to the records the patient already holds. The fifth checklist point asks the patient to read this structural decision before committing to travel.
Point 6 — Understand the aftercare model — week 1, week 6, month 3, and what happens at the patient's home country
Aftercare is the part of the pathway that runs longest. The surgical visit lasts five to seven days; osseointegration runs three to six months; the long-term review schedule runs for the working life of the implant — ten, fifteen, twenty years and beyond. The aftercare model the provider operates is therefore a more important structural signal than the surgical visit itself. The patient should be able to read in writing what happens within 1st week, 6th week, and 3rd month after surgery, who conducts each review, and how the patient's UK or home-country dentist is supported during the integration period.
A structured remote review schedule with the treating clinician — by video and a structured clinical questionnaire, with photographs of the surgical site contributed by the patient — is the cadence a responsibly run overseas pathway operates on. The week-1 review confirms initial soft-tissue healing and reviews the analgesic and chlorhexidine rinse protocol. The week-6 review confirms soft-tissue healing is complete and the implant is integrating to the expected pattern. The month-3 review confirms osseointegration is on track for the final prosthesis fitting. After the prosthesis is fitted, the long-term review schedule continues at month 6, year 1, and annually thereafter.
The patient's home dentist is the relationship of record for routine maintenance during the integration period and beyond. A responsibly run overseas pathway shares the pathway file (CBCT report, surgical record, implant passport, written clinical recommendation) with the home dentist on request, so any in-person review the home dentist conducts has the full clinical context. Where a provider does not document the aftercare cadence in writing, or does not share the pathway file with the home dentist, the patient is left to reconstruct the clinical record from intra-oral imaging years later — which is the failure mode the sixth checklist point is designed to surface.
Point 7 — Confirm the implant or prosthesis documentation pathway (the manufacturer's implant passport / patient pass)
Each implant placement should be recorded on the manufacturer's implant passport — the recognised industry-standard documentation that travels with the patient. Straumann's Patient Pass and Nobel Biocare's Implant Passport are the two most widely used examples; equivalent documentation is provided for other internationally certified implant systems. The passport captures the implant brand and system, the abutment configuration, the surgical date, the treating clinician, and the implant serial numbers. It is provided to the patient before they return home.
The implant passport matters because the patient's clinical relationship with the implant is long. Any future review anywhere in the world — routine maintenance with the patient's UK dentist, replacement of a prosthetic component a decade after placement, or unrelated dental or surgical work where the implant register is clinically relevant — has the technical record of the implant in front of it. Without that record, a clinician reviewing the implant in five or ten years has to reconstruct the surgical and prosthetic specification from intra-oral imaging, which is slower, more error-prone, and occasionally impossible.
The seventh checklist point asks the patient to confirm in writing, before any travel plan is made, that the manufacturer's implant passport will be issued at the partner facility and a duplicate retained at the coordination level. Where the provider responds with a generic "clinical record" or "surgical certificate" rather than the manufacturer's passport, that is a structural signal. The same principle applies to multi-unit prosthetic work, where the laboratory record of the ceramic system used (Ivoclar Vivadent IPS e.max for lithium disilicate units, VITA or Katana for zirconia units) should be documented alongside the manufacturer's record for the implants.
Putting the checklist together — what an evaluation conversation should sound like
An evaluation conversation that clears the seven points reads as a clinical document rather than a sales pitch. The verified clinician is identified at the start, with credentials verifiable against the relevant national register. The facility accreditation is referenced and verifiable against the JCI public register or the equivalent national body. The remote case review is conducted by the verified clinician and produces a written summary against the patient's CBCT scan, panoramic radiograph, clinical history, and photographic record. The written, customised estimate lists each clinical component as a separate line item.
The imaging-integration decision is documented in writing — what existing scans are accepted, what is repeated in-country and why, and what is itemised separately. The aftercare cadence is documented in writing — week 1, week 6, month 3, month 6, year 1, and annually thereafter, with the same verified clinician on file across the schedule. The manufacturer's implant passport is confirmed in writing as the document the patient will travel with after the surgical visit. Each of the seven points is verifiable independently, and each is documented in writing before any travel plan is made.
The ATDERA pathway is built so the seven points are answered in writing during the pre-consultation enquiry and the remote case review, before the patient is asked to confirm any travel. The pathway file (CBCT report, written clinical recommendation, customised estimate, verified clinician credential, facility accreditation reference, aftercare cadence, implant passport reference) is shared with the patient's UK or home-country dentist on request. Patients who decide not to travel after the evaluation are not pursued, and the pathway file is closed without further contact. The checklist is the structural lens; the pathway is one example of how the seven points map onto a coordinated international dental pathway.